February 22, 2024

libre de droit

Seres Therapeutics, Inc. (NASDAQ:MCRB) focuses on microbiome therapies. It makes use of a sophisticated platform to investigate the residing microorganisms contained in the human physique to create therapies to revive the microbiome steadiness and promote well being. Its main product is